|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$82,119,756 |
|
|
Indirect Value
|
$12,961,771,173 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,043,890,929 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 45 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GHDX |
Genomic Health Inc |
Director |
|
2012-05-07 |
4 |
B |
$28.25 |
$1,597,965 |
I/I |
56,540 |
230,439 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2010-08-10 |
4 |
B |
$14.66 |
$836,217 |
I/I |
56,705 |
4,464,986 |
2.25 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-01-11 |
4 |
B |
$5.28 |
$299,833 |
I/I |
56,822 |
953,666 |
1.5 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2009-05-29 |
4 |
S |
$4.12 |
$240,171 |
I/I |
(57,847) |
1,592,174 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2008-05-07 |
4 |
A |
$0.00 |
$0 |
I/I |
57,873 |
194,762 |
0 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2007-04-16 |
4 |
S |
$15.44 |
$949,466 |
I/I |
(61,364) |
4,080,113 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2006-06-29 |
4 |
B |
$4.08 |
$250,491 |
I/I |
61,443 |
3,710,965 |
2.25 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-06 |
4 |
S |
$12.14 |
$746,209 |
I/I |
(61,467) |
1,199,758 |
0 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2007-06-21 |
4 |
S |
$5.55 |
$342,460 |
I/I |
(61,690) |
6,011,855 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-01-18 |
4 |
B |
$9.00 |
$556,848 |
I/I |
61,872 |
137,470 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-23 |
4 |
B |
$28.12 |
$1,746,432 |
I/I |
62,098 |
7,707,045 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-03-09 |
4 |
B |
$18.28 |
$1,139,358 |
I/I |
62,325 |
606,709 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2010-08-09 |
4 |
B |
$14.80 |
$927,144 |
I/I |
62,610 |
4,408,281 |
2.25 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2016-01-27 |
4 |
B |
$6.98 |
$441,971 |
I/I |
63,345 |
12,616,525 |
1.5 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2005-03-23 |
4 |
B |
$4.96 |
$314,315 |
I/I |
63,376 |
133,975 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
N/A |
|
2006-09-08 |
4 |
B |
$14.12 |
$898,488 |
I/I |
63,408 |
233,732 |
0.01 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2006-08-09 |
4 |
B |
$4.05 |
$257,810 |
I/I |
63,657 |
1,480,319 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2006-08-09 |
4/A |
B |
$4.05 |
$257,810 |
I/I |
63,657 |
1,488,002 |
2.25 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-02-19 |
4 |
B |
$6.75 |
$433,973 |
I/I |
64,259 |
6,583,104 |
1.5 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2010-05-26 |
4 |
B |
$1.59 |
$102,196 |
I/I |
64,420 |
5,849,271 |
1.5 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-02-20 |
4 |
B |
$6.50 |
$421,324 |
I/I |
64,825 |
6,647,929 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-24 |
4 |
B |
$16.31 |
$1,062,827 |
I/I |
65,025 |
2,957,110 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2008-06-09 |
4 |
B |
$19.61 |
$1,280,112 |
I/I |
65,110 |
3,492,192 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-01-22 |
4 |
B |
$8.78 |
$571,758 |
I/I |
65,139 |
7,391,284 |
2.25 |
- |
|
INCY |
Incyte Corp |
10% Owner |
|
2003-09-22 |
4 |
B |
$4.97 |
$329,617 |
I/I |
66,300 |
1,479,155 |
1.5 |
- |
|
1397 Records found
|
|
Page 45 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|